Skip to main content
Home
Search
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
Search General Info
Search Education
Search Partnering Companies
×
×
Search General Info
Search
×
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
BIO Digital
Speakers & Presenters
Meet the experts speaking on our world-class education program.
June 10-11 & 14-18, 2021
Search
Event Menu
Event Menu
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
General Info
Education
Partnering Companies
×
Search General Info
Search
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
2020 BIO Digital Thought Leaders
All Speakers
Search
Filter
Session Types & Networking
Focus Areas
Interests
Company Presentations
Reset
Apply Filter
×
By Count
|
Alphabetical
Company Presentations
(341)
On Demand Sessions
(303)
Interactive Sessions
(124)
Interactive Super Sessions
(41)
Interactive Special Programs
(29)
Start-Up Stadium
(27)
Global Innovation Hubs
(24)
Interactive Plenaries
(22)
On Demand Special Programs
(17)
Interactive Fireside Chat
(10)
BioProcess International Theater
(5)
Show All
×
By Count
|
Alphabetical
COVID-19
(93)
Business Development and Finance
(51)
Digital Health
(46)
Oncology
(38)
Orphan and Rare Diseases
(34)
Infectious Disease and Vaccines
(32)
Value‚ Patient Access and Reimbursement
(28)
Brain Health
(27)
Personalized Medicine and Diagnostics
(26)
Next Generation Biotherapeutics
(23)
Emerging Opportunities in Global Markets
(21)
Cell & Gene Therapies and Genome Editing
(21)
Patient Advocacy
(17)
Highly Prevalent Chronic Diseases
(15)
Intellectual Property
(13)
Translational Research
(9)
Workforce Development
(9)
Emerging Therapies
(5)
Emerging Techniques, Technologies and Strategies
(1)
Show All
×
By Count
|
Alphabetical
Therapeutics
(126)
Oncology
(99)
COVID-19
(90)
Personalized Medicine
(81)
Preclinical/Research
(81)
Biologics
(76)
Business Development
(76)
CNS/Neurological
(73)
Small Molecules
(70)
Immunology
(69)
Gene/Cell Therapy
(64)
Infectious Diseases
(61)
Diagnostics
(60)
Genomics
(60)
Neurological Disease
(57)
Drug Delivery
(55)
Digital Health
(52)
Medical Devices
(47)
Cell Biology
(44)
Inflammatory Disease
(43)
Screening
(42)
Biomanufacturing
(41)
Translational Research
(41)
Vaccines
(40)
Regulatory Innovation
(40)
Molecular Diagnostics
(39)
Bioinformatics
(39)
Regenerative Medicine
(38)
Metabolic Diseases
(37)
Genetic Disorders
(35)
Intellectual Property
(35)
Contract Research
(34)
Cardiovascular
(33)
Research Tools
(32)
Autoimmune Disease
(31)
Immune Disorder
(31)
Brain Health
(30)
Stem Cell Research
(29)
Gastroenterology
(28)
Musculoskeletal
(26)
Hematology
(25)
Contract Manufacturing
(25)
Proteomics
(25)
Ophthalmology
(25)
Tissue Engineering
(25)
Respiratory
(24)
Transplant Medicine
(22)
Degeneration
(21)
Endocrinology
(20)
Pain Management
(20)
Gene Editing
(20)
Mental Health
(20)
Biobased Products
(19)
Renal
(19)
Nanotechnology
(18)
Urology
(17)
Workforce Development
(17)
Functional Genetics
(17)
Biodefense
(16)
Regulatory Science
(15)
Opioids
(15)
Pulmonary
(15)
Pharmacogenomics
(14)
Psychiatric
(14)
Reproductive Medicine
(13)
Dermatology
(13)
Imaging
(12)
Genitourinary
(12)
Transgenics
(12)
Genetically-enhanced Microbes
(12)
Ocuylar
(11)
One Health
(11)
Prophylaxis
(11)
Diversity
(10)
Nutraceuticals
(10)
Chemicals
(9)
Gynecology and obstetrics
(9)
Plant-made Pharmaceuticals
(8)
Biocatalysis
(8)
Multiline Global Biopharma
(8)
Bio-Energy
(7)
Nutritional Disorder
(7)
Aquaculture
(7)
Animal-made Pharmaceuticals
(7)
Toxicity and Intoxication
(6)
Micro Arrays
(6)
Personal Care
(6)
Growth Disorder
(5)
Industrial Chemicals
(5)
Industrial Enzymes
(5)
Microfluidics
(5)
Food Additives
(4)
Show All
×
Company Type
Privately Funded Company
(230)
Publicly Traded Company
(80)
Advocacy/Non-Profit/Other
(29)
Show All
Main Therapeutic Focus
Oncology
(67)
CNS/Neurological
(34)
Other
(31)
Multiple Therapeutics
(30)
Platform for Therapeutics
(19)
Tools/Drug Development Support Tech
(17)
Gene/Cell Therapy
(15)
Contract Research Organization
(12)
Infectious Diseases
(11)
Digital Health
(11)
Orphan/Rare Diseases
(9)
Contract Manufacturing Organization
(9)
Regenerative Medicine
(8)
Metabolic Diseases
(8)
Ophthalmology
(7)
Diagnostics
(6)
Gastrointestinal
(5)
Inflammation
(5)
Medical Devices
(5)
Dermatology
(4)
Immunology
(4)
Multiline Global Biopharma
(4)
Non-Profit/Patient Advocacy Group
(4)
Cardiovascular
(4)
Pain Management
(3)
COVID-19
(2)
Industrial & Environmental
(2)
Reproductive/Sexual Health
(2)
Respiratory
(2)
Food & Agriculture
(1)
Renewable Chemicals
(1)
Show All
Development Phase of Primary Product
Pre-Clinical
(92)
Other/Not Applicable
(67)
Phase I
(33)
Phase II
(33)
Multiple Products in Market
(33)
Phase III
(28)
Discovery
(13)
NDA Preparation / In Review
(9)
Phase IV
(1)
Show All
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
All Speakers
Search
Filter
Filter by letter
Please Select ...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
×
Filter Speakers
Session Types & Networking
Please Select ...
Company Presentations (341)
On Demand Sessions (303)
Interactive Sessions (124)
Interactive Super Sessions (41)
Interactive Special Programs (29)
Start-Up Stadium (27)
Global Innovation Hubs (24)
Interactive Plenaries (22)
On Demand Special Programs (17)
Interactive Fireside Chat (10)
BioProcess International Theater (5)
Focus Areas
Please Select ...
COVID-19 (93)
Business Development and Finance (51)
Digital Health (46)
Oncology (38)
Orphan and Rare Diseases (34)
Infectious Disease and Vaccines (32)
Value‚ Patient Access and Reimbursement (28)
Brain Health (27)
Personalized Medicine and Diagnostics (26)
Next Generation Biotherapeutics (23)
Emerging Opportunities in Global Markets (21)
Cell & Gene Therapies and Genome Editing (21)
Patient Advocacy (17)
Highly Prevalent Chronic Diseases (15)
Intellectual Property (13)
Translational Research (9)
Workforce Development (9)
Emerging Therapies (5)
Emerging Techniques, Technologies and Strategies (1)
Interests
Please Select ...
Therapeutics (126)
Oncology (99)
COVID-19 (90)
Personalized Medicine (81)
Preclinical/Research (81)
Biologics (76)
Business Development (76)
CNS/Neurological (73)
Small Molecules (70)
Immunology (69)
Gene/Cell Therapy (64)
Infectious Diseases (61)
Diagnostics (60)
Genomics (60)
Neurological Disease (57)
Drug Delivery (55)
Digital Health (52)
Medical Devices (47)
Cell Biology (44)
Inflammatory Disease (43)
Screening (42)
Biomanufacturing (41)
Translational Research (41)
Vaccines (40)
Regulatory Innovation (40)
Molecular Diagnostics (39)
Bioinformatics (39)
Regenerative Medicine (38)
Metabolic Diseases (37)
Genetic Disorders (35)
Intellectual Property (35)
Contract Research (34)
Cardiovascular (33)
Research Tools (32)
Autoimmune Disease (31)
Immune Disorder (31)
Brain Health (30)
Stem Cell Research (29)
Gastroenterology (28)
Musculoskeletal (26)
Hematology (25)
Contract Manufacturing (25)
Proteomics (25)
Ophthalmology (25)
Tissue Engineering (25)
Respiratory (24)
Transplant Medicine (22)
Degeneration (21)
Endocrinology (20)
Pain Management (20)
Gene Editing (20)
Mental Health (20)
Biobased Products (19)
Renal (19)
Nanotechnology (18)
Urology (17)
Workforce Development (17)
Functional Genetics (17)
Biodefense (16)
Regulatory Science (15)
Opioids (15)
Pulmonary (15)
Pharmacogenomics (14)
Psychiatric (14)
Reproductive Medicine (13)
Dermatology (13)
Imaging (12)
Genitourinary (12)
Transgenics (12)
Genetically-enhanced Microbes (12)
Ocuylar (11)
One Health (11)
Prophylaxis (11)
Diversity (10)
Nutraceuticals (10)
Chemicals (9)
Gynecology and obstetrics (9)
Plant-made Pharmaceuticals (8)
Biocatalysis (8)
Multiline Global Biopharma (8)
Bio-Energy (7)
Nutritional Disorder (7)
Aquaculture (7)
Animal-made Pharmaceuticals (7)
Toxicity and Intoxication (6)
Micro Arrays (6)
Personal Care (6)
Growth Disorder (5)
Industrial Chemicals (5)
Industrial Enzymes (5)
Microfluidics (5)
Food Additives (4)
Company Presentations
Please Select ...
Privately Funded Company (230)
Publicly Traded Company (80)
Advocacy/Non-Profit/Other (29)
Oncology (67)
CNS/Neurological (34)
Other (31)
Multiple Therapeutics (30)
Platform for Therapeutics (19)
Tools/Drug Development Support Tech (17)
Gene/Cell Therapy (15)
Contract Research Organization (12)
Infectious Diseases (11)
Digital Health (11)
Orphan/Rare Diseases (9)
Contract Manufacturing Organization (9)
Regenerative Medicine (8)
Metabolic Diseases (8)
Ophthalmology (7)
Diagnostics (6)
Gastrointestinal (5)
Inflammation (5)
Medical Devices (5)
Dermatology (4)
Immunology (4)
Multiline Global Biopharma (4)
Non-Profit/Patient Advocacy Group (4)
Cardiovascular (4)
Pain Management (3)
COVID-19 (2)
Industrial & Environmental (2)
Reproductive/Sexual Health (2)
Respiratory (2)
Food & Agriculture (1)
Renewable Chemicals (1)
Pre-Clinical (92)
Other/Not Applicable (67)
Phase I (33)
Phase II (33)
Multiple Products in Market (33)
Phase III (28)
Discovery (13)
NDA Preparation / In Review (9)
Phase IV (1)
Apply
Reset
×
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Chorom Pak
PRESIDENT AND CEO, LYNX BIOSCIENCES
How Can the Liquid Biopsy Market Realize Its $30B Potential?
San Diego, California, United States
Joe Palca, PhD
CORRESPONDENT, SCIENCE DESK, NPR
Science on the Front Lines & on the Front Page
United States
Deborah Palestrant
PARTNER, HEAD OF 4:59, 5AM VENTURES
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
Boston, Massachusetts, United States
Lauren Palestrini, PhD
DIRECTOR OF RESEARCH, MEDICAL TECHNOLOGY ENTERPRISE CONSORTIUM
How to Leverage Military Non-Dilutive Funding for Your Product Development Plan
Summerville, South Carolina, United States
Pan Pan
ASSOCIATE DIRECTOR, BUSINESS DEVELOPMENT, KLUS PHARMA INC.
KLUS Pharma Inc
Cranbury, New Jersey, United States
Agnès Pannier-Runacher
DEPUTY MINISTER TO THE MINISTER OF ECONOMY AND FINANCE, FRANCE
International Plenary Session: How are Global Leaders Collaborating to Combat the Pandemic?
France
Corrado Panno
VP, BUSINESS DEVELOPMENT, MAGELLAN METHOD, A DIVISION OF MAGELLAN RX MANAGEMENT
Reinventing Partnerships to Deliver Value for Patients & Society
United States
Kate Papp, PhD
CLINICAL NEUROPSYCHOLOGIST; ASSISTANT PROFESSOR, BRIGHAM AND WOMEN'S HOSPITAL; MASSACHUSETTS GENERAL HOSPITAL; HARVARD MEDICAL SCHOOL
The Emerging Role of Digital Biomarkers in Cognitive Impairment
Boston, Massachusetts, United States
Valerie Paradiz, PhD
VICE PRESIDENT OF SERVICES AND SUPPORTS, AUTISM SPEAKS
Patient-Centric 2.0: Are We Ready for Decentralized Trials?
Colorado, United States
Bhairavi Parikh, PhD
VP DIGITAL HEALTH, RESPIRATORY CARE, RESMED
Digital Health in Respiratory Care – The Next Frontier
San Diego, California, United States
John (Won-jun) Park
CMO (CHIEF MARKETING OFFICER), AIDOT INC.
AIDOT Inc.
Seoul, Korea, Republic of
Kyungmin Park
TEAM LEADER, SEOUL METROPOLITAN GOVERNMENT
Seoul Metropolitan Government_Invest Seoul Center, Seoul Business Agency
Seoul, Korea, Republic of
Hansoo Park
CTO, CO-FOUNDER, GENOME AND COMPANY
Genome and Company
Seongnam, Korea, Republic of
Hyunwoo Park
CEO, HEALTH PARK CO., LTD.
Health Park co.,ltd.
Seoul, Korea, Republic of
Yoon Jeong Park, PhD
CTO , NIBEC
NIBEC
SEOUL, Korea, Republic of
Jerry Parrott
PRESIDENT AND CEO, BIOMARKER STRATEGIES, LLC
BioMarker Strategies, LLC
Rockville, Maryland, United States
Maryam Parviz, PhD
CEO, SDIP INNOVATIONS PTY LTD
SDIP Innovations Pty Ltd
San Francisco, California, United States
Richard Pascoe
PRESIDENT AND CEO, HISTOGEN INC.
Histogen, Inc.
San Diego, California, United States
Danielle Pasqualone, JD, PhD
VICE PRESIDENT, INTELLECTUAL PROPERTY, ALECTOR LLC
WHY PATENTS STILL MATTER: Building Your Patent Portfolio for Global Collaborations
South San Francisco, California, United States
Andy Pasternak
CHIEF STRATEGY OFFICER, HORIZON THERAPEUTICS
Is It Time to Reconsider M&A’s Role in Portfolio Building?
Horizon Therapeutics
Lake Forest, Illinois, United States
Snehal Patel
CEO, GREENWICH LIFESCIENCES
Greenwich LifeSciences
Sugar Land, Texas, United States
Bakul Patel
DIRECTOR, DIVISION OF DIGITAL HEALTH, CENTER FOR DEVICES AND RADIOLOGICAL HEALTH, FDA
Digital Health: Innovation Meets Regulation
United States
Bray Patrick-Lake
DIRECTOR, STRATEGIC PARTNERSHIPS, EVIDATION HEALTH, INC.
Addressing the Unmet Need in Cardiovascular Disease Development
United States
Scott Paul
PRESIDENT, ALLIANCE FOR AMERICAN MANUFACTURING
International Trade in the Times of COVID-19
Ryan Pawell
CHIEF EXECUTIVE OFFICER, INDEE LABS
Indee Labs
Berkeley, California, United States
Cindy Perettie, BSc, MBA
CHIEF EXECUTIVE OFFICER , FOUNDATION MEDICINE
How Can the Liquid Biopsy Market Realize Its $30B Potential?
Cambridge, Massachusetts, United States
Ward Peterson, PhD
PRESIDENT AND CEO, SYMBERIX, INC.
Symberix, Inc.
Durham, North Carolina, United States
Chad Pettit
EXECUTIVE DIRECTOR, GLOBAL VALUE, ACCESS AND POLICY, BIOSIMILARS, AMGEN
How can the U.S. cultivate a strong and competitive biosimilars market?
Thousand Oaks, California, United States
Ed Pezalla, MD, MPH
FOUNDER AND CEO, ENLIGHTENMENT BIOCONSULT, LLC
Payers and Digital Therapeutics: How to Get Coverage When Doctors Prescribe Software
Daytona Beach, Florida, United States
Olivier Philippe
DIRECTOR OF BUSINESS DEVELOPMENT & CORPORATE RELATIONS, BIOPôLE SA
Biopôle SA
Epalinges, Switzerland
Maria Pineda
CO-FOUNDER & CEO, ENVISAGENICS
Envisagenics
New York, New York, United States
Agnieszka Piotrowska
ALLIANCE MANAGER, ARDIGEN
Ardigen
Krakow, Poland
Dominic Piscitelli
CHIEF FINANCIAL OFFICER, ORIC PHARMA
Capital Markets Crystal Ball: Strategies for Equity Financing
United States
Radu Pislariu
PRESIDENT & CEO, LAURENT PHARMACEUTICALS
Drug repurposing for new treatments of rare diseases: the academic, biotech, and investor perspective
Montreal, Quebec, Canada
Peter Pitts
PRESIDENT AND CO-FOUNDER, CENTER FOR MEDICINE IN THE PUBLIC INTEREST
In an Era of Partisan Stalemate, What Drug Pricing Policies Can the Executive Branch Enact Without Congressional Authority?
New York, New York, United States
Ivan Plavec
CBO, IMAGINAB
ImaginAb, Inc.
Inglewood, California, United States
Debbie Plouffe
VP BUSINESS DEVELLOPMENT, THE CENTER FOR AQUACULTURE TECHNOLOGIES
The Center for Aquaculture Technologies
Souris, Prince Edward Island, Canada
Jonathan Polak
CEO, MESENTECH INC
Mesentech Inc
Vancouver, British Columbia, Canada
Brian Pomper
PARTNER, AKIN GUMP STRAUSS HAUER & FELD LLP
International Trade in the Times of COVID-19
Washington, United States
Richard Pops
CHAIRMAN & CEO, ALKERMES, INC.
FDA Town Hall
Waltham, Massachusetts, United States
Michael Postow
MEDICAL ONCOLOGIST, MEMORIAL SLOAN KETTERING CANCER CENTER
What Was Hot at ASCO 2020? Highlights from the World’s Biggest Oncology Meeting
New York City, New York, United States
Steven Powell
CHAIRMAN, CAMBRIDGE COGNITION
Digital Biomarkers: A New Dawn in CNS R&D
Cambridge, United Kingdom
Michal Preminger, MBA, PhD
HEAD, JOHNSON & JOHNSON INNOVATION, EAST NORTH AMERICA, JOHNSON & JOHNSON
Brave Innovations: Public and Private Solutions to Advance Alzheimer’s Therapeutics and Diagnostic in a Risk-Averse Climate
Derisking Early Research and Increasing Likelihood of Clinical Success
Boston, Massachusetts, United States
Amy Price
DIRECTOR, CLIENT SERVICES
Patient Engagement in Gene and Cell Therapy: What is Different?
Denver, Colorado, United States
Daryl Pritchard, PhD
SENIOR VICE PRESIDENT, SCIENCE POLICY, PERSONALIZED MEDICINE COALITION
Access to Personalized Medicine Drives Utilization of Genomic Tests and Targeted Therapies
Washington, United States
Dennis Purcell, MBA
FOUNDER AND SENIOR ADVISOR, AISLING CAPITAL
Striking the delicate balance of externalizing biopharma R&D to maximize innovation: Strategies to buy vs. build
New York, New York, United States
Load More